Science Explorer Back to mapMap
Discussion

Enzon Pharmaceuticals (United States)

World rank, all time
#30,832
of 34,923
Rank in United States
#6,511
of 7,310
Research works
197
▲ 19% vs 2018-21
Citations
7.5k
38.3 per fractional work
Top-10% rate
6.4%
all institutions 10.0%
vs its own fields
1.07×
1.00× is exactly expected
Open access
17%
world 40%
International
12%
world 18%

Which fields of science does Enzon Pharmaceuticals (United States) work in?

In all years, 42% of research at Enzon Pharmaceuticals (United States) is in Life Sciences, 34% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (34%), Medicine (32%), Engineering (7%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 83 fractional works · 42.3% of its workBiochemistry, Genetics and Molecular Biology: 67 fractional works · 34.2% of its workMolecular Biology: 46 fractional works · 23.5% of its workCell Biology: 9 fractional works · 4.6% of its workGenetics: 4 fractional works · 2.1% of its workBiotechnology: 3 fractional works · 1.6% of its workCancer Research: 3 fractional works · 1.5% of its workBiochemistry: 1 fractional works · 0.5% of its workMolecular Medicine: 0 fractional works · 0.2% of its workImmunology and Microbiology: 6 fractional works · 2.9% of its workImmunology: 4 fractional works · 2.3% of its workMicrobiology: 1 fractional works · 0.3% of its workVirology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 5 fractional works · 2.4% of its workPharmaceutical Science: 3 fractional works · 1.8% of its workToxicology: 1 fractional works · 0.4% of its workPharmacology: 0 fractional works · 0.3% of its workAgricultural and Biological Sciences: 3 fractional works · 1.6% of its workFood Science: 2 fractional works · 0.9% of its workPlant Science: 1 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.2% of its workNeuroscience: 2 fractional works · 1.2% of its workEndocrine and Autonomic Systems: 1 fractional works · 0.5% of its workCellular and Molecular Neuroscience: 1 fractional works · 0.4% of its workSmaller subfields together: 1 fractional works · 0.3% of its workHealth Sciences: 68 fractional works · 34.4% of its workMedicine: 63 fractional works · 31.9% of its workOncology: 16 fractional works · 8.2% of its workRadiology, Nuclear Medicine and Imaging: 9 fractional works · 4.4% of its workPulmonary and Respiratory Medicine: 7 fractional works · 3.4% of its workPhysiology: 4 fractional works · 2.2% of its workPharmacology: 4 fractional works · 1.8% of its workPublic Health, Environmental and Occupational Health: 3 fractional works · 1.7% of its workInfectious Diseases: 3 fractional works · 1.5% of its workPediatrics, Perinatology and Child Health: 3 fractional works · 1.3% of its workGenetics: 3 fractional works · 1.3% of its workEpidemiology: 2 fractional works · 1.1% of its workSurgery: 2 fractional works · 0.9% of its workAnesthesiology and Pain Medicine: 1 fractional works · 0.7% of its workEmergency Medicine: 1 fractional works · 0.5% of its workHematology: 1 fractional works · 0.4% of its workBiochemistry: 1 fractional works · 0.3% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 0.3% of its workEndocrinology, Diabetes and Metabolism: 1 fractional works · 0.3% of its workCritical Care and Intensive Care Medicine: 0 fractional works · 0.2% of its workPathology and Forensic Medicine: 0 fractional works · 0.2% of its workNeurology: 0 fractional works · 0.2% of its workPsychiatry and Mental health: 0 fractional works · 0.2% of its workSmaller subfields together: 1 fractional works · 0.7% of its workVeterinary: 2 fractional works · 1.1% of its workSmall Animals: 2 fractional works · 1.1% of its workHealth Professions: 2 fractional works · 1.0% of its workMedical Laboratory Technology: 1 fractional works · 0.5% of its workGeneral Health Professions: 0 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.3% of its workNursing: 1 fractional works · 0.3% of its workNutrition and Dietetics: 1 fractional works · 0.3% of its workDentistry: 0 fractional works · 0.2% of its workPhysical Sciences: 42 fractional works · 21.1% of its workEngineering: 14 fractional works · 7.2% of its workCivil and Structural Engineering: 6 fractional works · 2.9% of its workSafety, Risk, Reliability and Quality: 2 fractional works · 0.9% of its workBiomedical Engineering: 1 fractional works · 0.7% of its workElectrical and Electronic Engineering: 1 fractional works · 0.6% of its workControl and Systems Engineering: 1 fractional works · 0.5% of its workMechanical Engineering: 1 fractional works · 0.5% of its workMechanics of Materials: 1 fractional works · 0.5% of its workAerospace Engineering: 1 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemistry: 14 fractional works · 6.8% of its workOrganic Chemistry: 10 fractional works · 5.2% of its workSpectroscopy: 2 fractional works · 0.9% of its workAnalytical Chemistry: 1 fractional works · 0.7% of its workMaterials Science: 10 fractional works · 5.2% of its workBiomaterials: 6 fractional works · 3.1% of its workPolymers and Plastics: 2 fractional works · 1.0% of its workMaterials Chemistry: 2 fractional works · 0.8% of its workSurfaces, Coatings and Films: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEnvironmental Science: 2 fractional works · 1.0% of its workEcology: 1 fractional works · 0.6% of its workSmaller subfields together: 1 fractional works · 0.4% of its workComputer Science: 2 fractional works · 0.8% of its workComputational Theory and Mathematics: 1 fractional works · 0.6% of its workSmaller subfields together: 0 fractional works · 0.2% of its workChemical Engineering: 0 fractional works · 0.1% of its workEarth and Planetary Sciences: 0 fractional works · 0.1% of its workSocial Sciences: 4 fractional works · 2.1% of its workSocial Sciences: 2 fractional works · 1.2% of its workSociology and Political Science: 1 fractional works · 0.4% of its workPolitical Science and International Relations: 1 fractional works · 0.3% of its workSmaller subfields together: 1 fractional works · 0.4% of its workPsychology: 1 fractional works · 0.5% of its workClinical Psychology: 1 fractional works · 0.5% of its workBusiness, Management and Accounting: 0 fractional works · 0.3% of its workStrategy and Management: 0 fractional works · 0.3% of its workArts and Humanities: 0 fractional works · 0.2% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.0% of its workALL ITS WORKEnzonPharmaceuticals…197fractional works, all years
Life Sciences42%Physical Sciences21%Health Sciences34%Social Sciences2%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 22 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology6734.2%
    2. Immunology and Microbiology62.9%
    3. Pharmacology, Toxicology and Pharmaceutics52.4%
    4. Agricultural and Biological Sciences31.6%
    5. Neuroscience21.2%
    1. Medicine6331.9%
    2. Veterinary21.1%
    3. Health Professions21.0%
    4. Nursing10.3%
    5. Dentistry00.2%
    1. Engineering147.2%
    2. Chemistry146.8%
    3. Materials Science105.2%
    4. Environmental Science21.0%
    5. Computer Science20.8%
    6. Chemical Engineering00.1%
    7. Earth and Planetary Sciences00.1%
    1. Social Sciences21.2%
    2. Psychology10.5%
    3. Business, Management and Accounting00.3%
    4. Arts and Humanities00.2%
    5. Economics, Econometrics and Finance00.0%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.55× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.38× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 6.59× its world share, 1 worksImmunology and Micro…Neuroscience: 2.16× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 15.75× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 2.01× its world share, 0 worksChemical EngineeringChemistry: 9.94× its world share, 2 worksChemistryComputer Science: 0.19× its world share, 0 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringEnvironmental Science: 0.46× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.74× its world share, 0 worksMaterials ScienceHealth Professions: 0.72× its world share, 0 worksHealth ProfessionsMedicine: 2.04× its world share, 4 worksMedicineNursing: 2.39× its world share, 0 worksNursingVeterinary: 25.80× its world share, 0 worksVeterinaryBusiness, Management and Accounting: 1.63× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 0.03× its world share, 0 worksEconomics, Econometr…Social Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Veterinary, 25.8×. Every wedge is a field page.

All 18 fields, with their numbers
  1. Veterinary25.80×0 works
  2. Pharmacology, Toxicology and Pharmaceutics15.75×0 works
  3. Chemistry9.94×2 works
  4. Immunology and Microbiology6.59×1 works
  5. Nursing2.39×0 works
  6. Neuroscience2.16×0 works
  7. Medicine2.04×4 works
  8. Chemical Engineering2.01×0 works
  9. Business, Management and Accounting1.63×0 works
  10. Biochemistry, Genetics and Molecular Biology1.38×1 works
  11. Materials Science0.74×0 works
  12. Health Professions0.72×0 works
  13. Agricultural and Biological Sciences0.55×0 works
  14. Environmental Science0.46×0 works
  15. Computer Science0.19×0 works
  16. Engineering0.04×0 works
  17. Economics, Econometrics and Finance0.03×0 works
  18. Social Sciences0.01×0 works

Who are the top researchers at Enzon Pharmaceuticals (United States)?

Ranked on the quality score, Lee M. Greenberger, Yixian Zhang and David R. Filpula lead among researchers whose main affiliation is Enzon Pharmaceuticals (United States).

  1. 1 Lee M. Greenberger United States · #188,816 worldwide 7.7k citations · 200 works
  2. 2 Yixian Zhang United States · #735,117 worldwide 4.5k citations · 155 works
  3. 3 David R. Filpula United States · #736,341 worldwide 3.5k citations · 45 works
  4. 4 Aby Buchbinder United States · #1,053,270 worldwide 5.9k citations · 79 works
  5. 5 Robert Shorr United States · #1,370,017 worldwide 3.2k citations · 79 works
  6. 6 Richard B. Greenwald United States · #1,544,823 worldwide 3.1k citations · 54 works
  7. 7 D Filpula United States · #1,547,877 worldwide 1.6k citations · 19 works
  8. 8 Raj Bandaru United States · #2,048,875 worldwide 752 citations · 27 works
  9. 9 Charles D. Conover United States · #2,065,401 worldwide 2.1k citations · 25 works
  10. 10 Annapurna Pendri United States · #2,098,673 worldwide 1.9k citations · 41 works
All ranked researchers at Enzon Pharmaceuticals (United States)

What are the most cited papers from Enzon Pharmaceuticals (United States)?

The most cited paper from Enzon Pharmaceuticals (United States) is "Effective drug delivery by PEGylated drug conjugates" (Richard B. Greenwald, Yun Hui Choe, Jeffrey M. McGuire et al., 2003), with 872 citations. Next come "PEG drugs: an overview" (351) and "An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability" (318).

Most cited papers
#PaperReleasedCitations
1 Effective drug delivery by PEGylated drug conjugates Richard B. Greenwald, Yun Hui Choe, Jeffrey M. McGuire et al. · Advanced Drug Delivery Reviews Review Feb 2003 872
2 PEG drugs: an overview R. B. GREENWALD · Journal of Controlled Release Jul 2001 351
3 An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability M. Whitlow, Brian A. Bell, Sheau-Line Y. Feng et al. · Protein Engineering Design and Selection 1993 318
4 The origin of pegnology Frank F. Davis · Advanced Drug Delivery Reviews Jun 2002 279
5 The therapeutic value of poly(ethylene glycol)-modified proteins Mary L. Nucci, Robert Shorr, Abraham Abuchowski · Advanced Drug Delivery Reviews Review Mar 1991 278
All 60 most cited papers, with filters and sorting

Which keywords describe research at Enzon Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Glycosylation, Cancer Therapy, Monoclonal Antibodies, Therapeutic Antibodies, Drug Discovery, Genomic Stability and Gene Therapy.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Chemotherapy14▲ 9.8×9 topics
  2. Glycosylation12▲ 28×3 topics
  3. Nanoparticles11▲ 4.1×10 topics
  4. Cancer10▲ 3.7×14 topics
  5. Cancer Therapy10▲ 7.7×7 topics
  6. Monoclonal Antibodies9▲ 32×3 topics
  7. Therapeutic Antibodies9▲ 35×2 topics
  8. Drug Discovery9▲ 11×5 topics
  9. Genomic Stability8▲ 46×2 topics
  10. Gene Therapy8▲ 16×5 topics
  11. Immunotherapy8▲ 6.3×9 topics
  12. Genetic Variants8▲ 19×4 topics
  13. Clinical Trials8▲ 6.4×7 topics
  14. Targeted Therapy8▲ 18×5 topics
  15. Biomedical Applications7▲ 3.5×9 topics
  16. Hemoglobin7▲ 128×1 topic
  17. Scavenger Receptor7▲ 128×1 topic
  18. Anticancer Drugs7▲ 79×2 topics
  19. Neurotoxicity6▲ 18×4 topics
  20. DNA6▲ 103×1 topic
  21. Topoisomerases6▲ 103×1 topic
  22. Drug Delivery6▲ 6.6×5 topics
  23. Antibody Engineering6▲ 31×1 topic
  24. Fc Receptors6▲ 31×1 topic
  25. Tumor Targeting6▲ 22×3 topics
  26. Protein-Protein Interactions6▲ 27×3 topics
  27. Foldamers5▲ 34×1 topic
  28. Peptide Synthesis5▲ 34×1 topic
  29. Apoptosis5▲ 6.8×7 topics
  30. Genomic Profiling5▲ 26×2 topics
  31. Monoclonal Antibody5▲ 36×2 topics
  32. RNA Interference5▲ 23×2 topics
  33. Immune System5▲ 7.7×3 topics
  34. Gene Silencing5▲ 20×1 topic
  35. siRNA Delivery5▲ 32×1 topic
  36. Chemotherapy-Induced Peripheral Neuropathy4▲ 45×1 topic
  37. Glycans4▲ 27×1 topic
  38. Mucins4▲ 27×1 topic
  39. Taxanes4▲ 45×1 topic
  40. Therapeutic Targets4▲ 8.8×6 topics

Which research topics does Enzon Pharmaceuticals (United States) publish most on?

By volume in 2022-now: Analytical Methods in Pharmaceuticals, Supply Chain Resilience and Risk Management, Analytical Chemistry and Chromatography and Animal testing and alternatives.

  1. 1 Analytical Methods in Pharmaceuticals Analytical Chemistry 1 works
  2. 2 Supply Chain Resilience and Risk Management Strategy and Management 0 works
  3. 3 Analytical Chemistry and Chromatography Spectroscopy 0 works
  4. 4 Animal testing and alternatives Small Animals 0 works
  5. 5 Medical Device Sterilization and Disinfection Microbiology 0 works
  6. 6 Antibiotics Pharmacokinetics and Efficacy Pharmacology 0 works
  7. 7 Pain Mechanisms and Treatments Physiology 0 works
  8. 8 Diagnosis and Treatment of Venous Diseases Surgery 0 works
  9. 9 Dermatologic Treatments and Research Dermatology 0 works
  10. 10 Drug-Induced Hepatotoxicity and Protection Pharmacology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available16.8%not open83.2%

World: 40% of research is openly available.

with international co-authors11.8%domestic only88.2%

World: 18% is written across borders.

How has Enzon Pharmaceuticals (United States)'s research output changed?

Output in 2022-2025 was 19% higher than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Enzon Pharmaceuticals (United States) as a percentage of every work published that year, 0.000049% in 2024.

still counting0.00050%0.0010%0.0015%Enzon Pharmaceuticals (United States)0.000045% in 202519801990200020102020

Fractional works of Enzon Pharmaceuticals (United States) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Piscataway

All research institutions in Piscataway

Share Enzon Pharmaceuticals (United States)'s ranking

Enzon Pharmaceuticals (United States) on Science Explorer

A card with Enzon Pharmaceuticals (United States)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Enzon Pharmaceuticals (United States). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.